Fox2Now St. Louis

Adoption of Rezūm® and Urolift® Devices Set to Increase Global BPH Treatment Device Market to Reach $1.7B by 2028

Both Rezūm® and Urolift® are relatively new treatments for BPH, as countries begin reimbursing for these treatments, the market will grow significantly.” — Dr. Kamran Zamanian, Senior Partner and CEO ...
Nasdaq

Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 ...

New real-world data findings along with new product evolutions demonstrate why the UroLift® System is the right solution for most BPH patients WAYNE, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Teleflex ...
WSPA

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over ...

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 ...